Us Bancorp \De\ Avrobio, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$5.53 - $9.28 $1,039 - $1,744	-188 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$12.19 - $22.96 $2,291 - $4,316	188 New	188 $3,000
Q1 2020 May 13, 2020	SELL	$10.08 - $27.21 $2,096 - $5,659	-208 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$13.05 - $21.88 $443 - $743	-34 Reduced 14.05%	208 $4,000
Q3 2019 Nov 08, 2019	BUY	$14.12 - $23.44 $3,417 - $5,672	242 New	242 $3,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.